These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17580734)

  • 21. Comparison of once daily versus twice daily oral nitrates in stable angina pectoris.
    Kardas P;
    Am J Cardiol; 2004 Jul; 94(2):213-6. PubMed ID: 15246905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atenolol is associated with lower day-of-surgery heart rate compared to long- and short-acting metoprolol.
    Schonberger RB; Brandt C; Feinleib J; Dai F; Burg MM
    J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):298-304. PubMed ID: 22889605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Betaxolol in the treatment of stable angina pectoris.
    Chrysant SG; Bittar N
    Cardiology; 1994; 84(4-5):316-21. PubMed ID: 8187119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure.
    Kukin ML; Mannino MM; Freudenberger RS; Kalman J; Buchholz-Varley C; Ocampo O
    J Am Coll Cardiol; 2000 Jan; 35(1):45-50. PubMed ID: 10636257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Clark-Turner N
    Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy and compliance in angina pectoris--analysis of a physician and patient survey].
    Schoberberger R; Schwarz B; Kunze M
    Wien Med Wochenschr; 1989 Jul; 139(14):321-30. PubMed ID: 2570496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
    Brun J
    J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
    Nordlander R; Walter M
    Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial.
    Kardas P
    J Antimicrob Chemother; 2007 Mar; 59(3):531-6. PubMed ID: 17289766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between metoprolol orally osmotic once daily and metoprolol two or three times daily in suppressing exercise-induced and daily myocardial ischemia.
    Tzivoni D; Medina A; David D; Barzilai Y; Gavish A; Shatboon D; Keren A; Brunel P
    Am J Cardiol; 1996 Dec; 78(12):1362-8. PubMed ID: 8970407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing the effectiveness of converting patients to long-acting antianginal medications: The Quality of Life in Angina Research Trial (QUART).
    Spertus JA; Dewhurst T; Dougherty CM; Nichol P
    Am Heart J; 2001 Apr; 141(4):550-8. PubMed ID: 11275919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [TTS-nitroglycerin and slow-release metoprolol: efficacy in patients with stable exercise-induced angina].
    Scardi S; Pandullo C; Pivotti F; Pollavini G
    G Ital Cardiol; 1985 May; 15(5):526-32. PubMed ID: 2865188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained-release diltiazem versus metoprolol in stable angina pectoris.
    Posma JL; van Dijk RB; Lie KI
    Eur Heart J; 1989 Oct; 10(10):923-7. PubMed ID: 2598950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.